Evidence map›Paper›PMID 41988626›Full record

ArticleCureus2026

Unveiling a Rare and Aggressive Bladder Tumor: A Case Report of Plasmacytoid Urothelial Carcinoma.

Fatima Zahra Bouayed, Mohammed Amine Guerrouaz, Hanane Sebbar, Ahmed BenSghier, Soufiane Berhili, Mohamed Moukhlissi, Loubna Mezouar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatima Zahra BouayedRadiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Mohammed Amine GuerrouazRadiation Therapy, Mohammed VI University Hospital, Oujda, MAR.
Hanane SebbarPathology, Mohammed VI University Hospital, Oujda, MAR.
Ahmed BenSghierRadiation Oncology, Mohammed VI University Hospital, Oujda, MAR.
Soufiane BerhiliRadiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Mohamed MoukhlissiRadiotherapy, Mohammed VI University Hospital, Oujda, MAR.
Loubna MezouarRadiation Oncology, Mohammed VI University Hospital, oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 1991, Sahin et al. reported the first documented case of plasmacytoid urothelial carcinoma (PUC). A rare and highly aggressive subtype that was recently incorporated into the WHO classification of urothelial carcinomas, representing 1-3% of cases of bladder cancers. The tumor cells are characterized by eccentrically placed nuclei with abundant eosinophilic cytoplasm and demonstrate positive immunostaining for CD138, and this variant is generally linked to an unfavorable prognosis. In this article, we present the case of a 61-year-old male diagnosed with PUC managed with concurrent chemoradiotherapy.

Indexed as

concomitant chemo-radiotherapyplasmacytoidplasmacytoid urothelial carcinomaplasmacytoid variant urothelial carcinomaradiation oncoolgy

Identifiers

PMID41988626
PMCPMC13078917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.